Transaction · 0001193125-26-371388

Maduck Sean

Maduck Sean, SR, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 25085.000000 shares for an estimated $3147354.75. Reported holdings after the transaction were 15625.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
CORTCORCEPT THERAPEUTICS INC
Filing timeAug 27
Trade dateAug 25, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

CORT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CORT since 2026-08-27Filed 8 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-371388
Common Stock
Transaction date
Aug 25, 2026
Filed Aug 27, 2026, 08:30 PM · 2d delay
Shares
25.0k sh
$12.5k per share
Estimated value
-$314M
Computed from shares × price
Holdings after
15.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction Large Sale Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to th…

  2. F2

    This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction.

  3. F3

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $125.00 to $125.98 per share. Information on the exact number of shares sold at each…

  4. F4

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $126.00 to $126.23 per share. Information on the exact number of shares sold at each…

  5. F5

    Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.

  6. F6

    Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager.

  7. F7

    Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.

  8. F8

    Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.

  9. F9

    Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

  10. F10

    Fully exercisable.

Original filing · 0001193125-26-371388
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CORT